Hot News

藥明生物宣布大額購回,股價大漲超5%,港股通醫藥ETF(159776)漲超1%亅ETF觀察 @ 2023-12-06T16: Back Hot News
Keyword:藥明生物
Concept:
《大行報告》大華繼顯降藥明生物評級至「沽售」 削目標價至22元
《大行報告》大和降藥明生物(02269.HK)評級至「持有」 目標價削至33元
《大行報告》麥格理降藥明生物(02269.HK)評級至「中性」 目標價下調至38元
《大行報告》瑞銀削藥明生物(02269.HK)目標價至39元 指引下調導致投資者情緒疲弱

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.